Cholestatic Pruritus Associated with PBC: Understanding Unmet Patient Needs and Treatment Strategies

Auteur(s): Annenberg Center for Health Sciences
Écouter gratuitement

  • Résumé

  • Pruritus occurs in up to 70% of patients with primary biliary cholangitis (PBC), can be severe, and lead to increased morbidity-including worsening fatigue and quality of sleep. Standard of care treatment has relied on a variety of medications with limited effectiveness and tolerability adding to the patient disease burden. Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team.
    Annenberg Center for Health Sciences
    Voir plus Voir moins
Hygiene & Healthy Living Troubles et maladies
Voir plus Voir moins
Épisodes
  • Interprofessional Patient Case

    Interprofessional Patient Case
    Feb 11 2025

    Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team. They also explore safety and efficacy data from trials of emerging treatment options including ileal bile acid transporter (IBAT) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists.
    Voir plus Voir moins
    5 min
  • Investigational Therapies

    Investigational Therapies
    Feb 11 2025
    Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team. They also explore safety and efficacy data from trials of emerging treatment options including ileal bile acid transporter (IBAT) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists.
    Voir plus Voir moins
    5 min
  • Current Treatment Options

    Current Treatment Options
    Feb 11 2025

    Alan Bonder, MD, and Kris Kowdley, MD, discuss unmet patient needs, pruritus assessment tools, and guideline-based therapy provided by an interprofessional care team. They also explore safety and efficacy data from trials of emerging treatment options including ileal bile acid transporter (IBAT) inhibitors and peroxisome proliferator-activated receptor (PPAR) agonists.
    Voir plus Voir moins
    16 min

Ce que les auditeurs disent de Cholestatic Pruritus Associated with PBC: Understanding Unmet Patient Needs and Treatment Strategies

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.